CLSA Wire

Earlier this month, the Centers for Medicare and Medicaid Services (CMS) released the final “Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary” rule (42 CFR Part 405). 

On Tuesday, January 26, Governor Newsom revised the vaccine rollout plan to help streamline allocation and distribution.

This November, voters will have the opportunity to vote yes on Proposition 14 to authorize $5.5 billion in state general obligation bonds to continue the advancement of treatments and cures here in
California.

The new Fiscal Year (FY) will begin at midnight tonight on October 1st.  At the time this update was prepared on September 29th, a government shutdown is unlikely following the House passage of a continuing resolution (CR) to fund the government at FY20 levels through December 11, 2020. 

CLSA is profoundly disappointed by the Administration’s decision to move forward with the flawed concept of a ‘Most Favored Nation’ policy that threatens the innovative life sciences ecosystem and patient access to cutting edge biomedical advancement.